Atomoxetine-induced electrocardiogram changes

Rajesh, A. S.; Bates, G.; Wright, J. G. C.
December 2006
Archives of Disease in Childhood;Dec2006, Vol. 91 Issue 12, p1023
Academic Journal
The article focuses on a study of an 11-year-old child with attention deficit hyperactivity disorder (ADHD) who developed unusual cardiac repolarization changes related to palpitations on treatment with a standard dose of atomoxetine. After 10 months of treatment, the child developed sensations of fluttering in his chest. Electrocardiogram (ECG) revealed unusual repolarization changes. However, ECG abnormalities and symptoms of ADHD disappeared after stopping the medication.


Related Articles

  • Cardiovascular Evaluation May Be Useful for Children Being Treated for ADHD. Dziedzic, Jessica // Neuropsychiatry Reviews;Jun2008, Vol. 9 Issue 6, p8 

    The article discusses the scientific statement which recommends electrocardiography (ECG) to evaluate children being treated for attention-deficit hyperactivity disorder (ADHD). Authors of the statement suggest that ECG, patient and family history and physical examination may help physicians...

  • EFFECTIVENESS OF FAMILY, CHILD, AND FAMILY-CHILD BASED INTERVENTION ON ADHD SYMPTOMS OF STUDENTS WITH DISABILITIES. Malekpour, Mokhtar; Aghababaei, Sara; Hadi, Samira // International Journal of Special Education;2014, Vol. 29 Issue 2, p29 

    The aim of the present study was to investigate and compare the effectiveness of family, child, and family-child based intervention on the rate of ADHD symptoms in third grade students. The population for this study was all of students with ADHD diagnoses in the city of Isfahan, Iran. The...

  • A Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled, Dose-Optimization Study of the Methylphenidate Transdermal System for the Treatment of ADHD in Adolescents. Findling, Robert L.; Turnbow, John; Burnside, John; Melmed, Raun; Civil, Rich; Li, Yunfeng // CNS Spectrums: The International Journal of Neuropsychiatric Med;Jul2010, p2 

    Introduction: The current report evaluates the efficacy and safety of methylphenidate transdermal system (MTS) compared with placebo transdermal system (PTS) in adolescents with attention-deficit/hyperactivity disorder (ADHD). Methods: A total of 217 subjects participated in a 7-week,...

  • Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder. Lamberti, Marco; Italiano, Domenico; Guerriero, Laura; D'Amico, Gessica; Siracusano, Rosamaria; Ingrassia, Massimo; Germanò, Eva; Calabrò, Maria Pia; Spina, Edoardo; Gagliano, Antonella // Neuropsychiatric Disease & Treatment;2015, Vol. 11, p1169 

    Attention-deficit hyperactivity disorder is a frequent condition in children and often extends into adulthood. Use of immediate-release methylphenidate (MPH) has raised concerns about potential cardiovascular adverse effects within a few hours after administration. This study was carried out to...

  • Life-threatening QT prolongation in a boy with attention-deficit/hyperactivity disorder on atomoxetine. Yamaguchi, Hiroshi; Nagumo, Kiyoshi; Nakashima, Taiji; Kinugawa, Yoshikazu; Kumaki, Satoru // European Journal of Pediatrics;Dec2014, Vol. 173 Issue 12, p1631 

    As a noncentral nerve-stimulating agent blocking reuptake of noradrenalin, atomoxetine is used for treatment of attention-deficit/hyperactivity disorder (ADHD). Because it has less potential for addiction and abuse and improves core symptoms of ADHD, it is commonly prescribed in many children...

  • Epistasis between neurochemical gene polymorphisms and risk for ADHD. Segurado, Ricardo; Bellgrove, Mark A.; Manconi, Francesca; Gill, Michael; Hawi, Ziarah // European Journal of Human Genetics;May2011, Vol. 19 Issue 5, p577 

    A number of genes with function related to synaptic neurochemistry have been genetically associated with attention deficit/hyperactivity disorder. However, susceptibility to the development of common psychiatric disorders by single variants acting alone, can so far only explain a small...

  • The impact of study design and diagnostic approach in a large multi-centre ADHD study. Part 1: ADHD symptom patterns. Müller, Ueli C.; Asherson, Philip; Banaschewski, Tobias; Buitelaar, Jan K.; Ebstein, Richard P.; Eisenberg, Jaques; Gill, Michael; Manor, Iris; Miranda, Ana; Oades, Robert D.; Roeyers, Herbert; Rothenberger, Aribert; Sergeant, Joseph A.; Sonuga-Barke, Edmund J. S.; Thompson, Margaret; Faraone, Stephen V.; Steinhausen, Hans-Christoph // BMC Psychiatry;2011, Vol. 11 Issue 1, p54 

    Background: The International Multi-centre ADHD Genetics (IMAGE) project with 11 participating centres from 7 European countries and Israel has collected a large behavioural and genetic database for present and future research. Behavioural data were collected from 1068 probands with the combined...

  • An investigation into deficit hyperactivity disorder. Essex, Charles // BMJ: British Medical Journal (International Edition);12/6/2003, Vol. 327 Issue 7427, p1353 

    Reviews a radio broadcast called "An investigation into attention deficit hyperactivity disorder," which was aired on the BBC Radio 4 program "Case Notes" at 9 p.m. on November 25, 2003.

  • Attention Deficit Hyperactivity Disorder Screening Electrocardiograms: A Community-Based Perspective. Shahani, Shilpa; Evans, William; Mayman, Gary; Thomas, Vincent // Pediatric Cardiology;Mar2014, Vol. 35 Issue 3, p485 

    Screening electrocardiograms (EKGs) for attention deficit hyperactivity disorder (ADHD) medication administration is controversial. We reviewed our experience as a community-based cardiology group. We reviewed all ADHD screening EKGs during a 2-year period. We evaluated whether screening EKGs...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics